A Phase II and Biomarker Study of Sorafenib Combined with Modified FOLFOX in Patients with Advanced Hepatocellular Carcinoma.
索拉非尼联合改良FOLFOX方案治疗晚期肝细胞癌患者的II期生物标志物研究
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-18-0847
Goyal Lipika, Zheng Hui, Abrams Thomas A, Miksad Rebecca, Bullock Andrea J, Allen Jill N, Yurgelun Matthew B, Clark Jeffrey W, Kambadakone Avinash, Muzikansky Alona, Knowles Michelle, Galway Aralee, Afflitto Anthony J, Dinicola Caroline F, Regan Eileen, Hato Tai, Mamessier Emilie, Shigeta Kohei, Jain Rakesh K, Duda Dan G, Zhu Andrew X